Zevra Therapeutics Statistics
Total Valuation
ZVRA has a market cap or net worth of $409.93 million. The enterprise value is $415.61 million.
Important Dates
The last earnings date was Tuesday, March 11, 2025, after market close.
Earnings Date | Mar 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ZVRA has 54.12 million shares outstanding. The number of shares has increased by 30.46% in one year.
Current Share Class | 54.12M |
Shares Outstanding | 54.12M |
Shares Change (YoY) | +30.46% |
Shares Change (QoQ) | +11.85% |
Owned by Insiders (%) | 6.61% |
Owned by Institutions (%) | 48.56% |
Float | 42.73M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 100.26 |
PS Ratio | 15.38 |
Forward PS | 4.57 |
PB Ratio | 10.62 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 17.60 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.53, with a Debt / Equity ratio of 1.52.
Current Ratio | 2.53 |
Quick Ratio | 2.35 |
Debt / Equity | 1.52 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -11.84 |
Financial Efficiency
Return on equity (ROE) is -207.84% and return on invested capital (ROIC) is -52.90%.
Return on Equity (ROE) | -207.84% |
Return on Assets (ROA) | -31.03% |
Return on Invested Capital (ROIC) | -52.90% |
Return on Capital Employed (ROCE) | -60.39% |
Revenue Per Employee | $400,203 |
Profits Per Employee | -$1.79M |
Employee Count | 59 |
Asset Turnover | 0.13 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ZVRA has paid $15.37 million in taxes.
Income Tax | 15.37M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +31.21% in the last 52 weeks. The beta is 1.98, so ZVRA's price volatility has been higher than the market average.
Beta (5Y) | 1.98 |
52-Week Price Change | +31.21% |
50-Day Moving Average | 7.89 |
200-Day Moving Average | 7.56 |
Relative Strength Index (RSI) | 42.42 |
Average Volume (20 Days) | 507,742 |
Short Selling Information
The latest short interest is 5.57 million, so 10.30% of the outstanding shares have been sold short.
Short Interest | 5.57M |
Short Previous Month | 5.61M |
Short % of Shares Out | 10.30% |
Short % of Float | 13.04% |
Short Ratio (days to cover) | 12.47 |
Income Statement
In the last 12 months, ZVRA had revenue of $23.61 million and -$105.51 million in losses. Loss per share was -$2.28.
Revenue | 23.61M |
Gross Profit | 16.20M |
Operating Income | -87.00M |
Pretax Income | -50.87M |
Net Income | -105.51M |
EBITDA | -80.61M |
EBIT | -87.00M |
Loss Per Share | -$2.28 |
Full Income Statement Balance Sheet
The company has $69.50 million in cash and $60.30 million in debt, giving a net cash position of $9.20 million or $0.17 per share.
Cash & Cash Equivalents | 69.50M |
Total Debt | 60.30M |
Net Cash | 9.20M |
Net Cash Per Share | $0.17 |
Equity (Book Value) | 39.67M |
Book Value Per Share | 0.74 |
Working Capital | 51.96M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -69.67M |
Capital Expenditures | n/a |
Free Cash Flow | -69.67M |
FCF Per Share | -$1.29 |
Full Cash Flow Statement Margins
Gross Margin | 68.59% |
Operating Margin | -368.47% |
Pretax Margin | -381.76% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ZVRA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -30.46% |
Shareholder Yield | n/a |
Earnings Yield | -24.84% |
FCF Yield | -16.40% |
Analyst Forecast
The average price target for ZVRA is $22.29, which is 194.26% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $22.29 |
Price Target Difference | 194.26% |
Analyst Consensus | Strong Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | 75.49% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on December 28, 2020. It was a reverse split with a ratio of 0.0625:1.
Last Split Date | Dec 28, 2020 |
Split Type | Reverse |
Split Ratio | 0.0625:1 |
Scores
ZVRA has an Altman Z-Score of -3.76 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.76 |
Piotroski F-Score | 2 |